N-[5-[6-cyano-5-[[2-(3-methylmorpholin-4-yl)-2-oxoethyl]amino]-3-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide
C21H23N7O3 — CID 121271891
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[6-cyano-5-[[2-(3-methylmorpholin-4-yl)-2-oxoethyl]amino]-3-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide
N-[5-[6-cyano-5-[[2-(3-methylmorpholin-4-yl)-2-oxoethyl]amino]-3-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide (PubChem CID 121271891) has the molecular formula C21H23N7O3 and a molecular weight of 421.46 g/mol. Its IUPAC name is N-[5-[6-cyano-5-[[2-(3-methylmorpholin-4-yl)-2-oxoethyl]amino]-3-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide.
Molecular Properties
| Compound Name | N-[5-[6-cyano-5-[[2-(3-methylmorpholin-4-yl)-2-oxoethyl]amino]-3-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide |
|---|---|
| PubChem CID | 121271891 |
| Molecular Formula | C21H23N7O3 |
| Molecular Weight | 421.46 g/mol |
| Exact Mass | 421.19 |
| IUPAC Name | N-[5-[6-cyano-5-[[2-(3-methylmorpholin-4-yl)-2-oxoethyl]amino]-3-pyridinyl]pyrazin-2-yl]cyclopropanecarboxamide |
| SMILES | CC1COCCN1C(=O)CNc1cc(-c2cnc(NC(=O)C3CC3)cn2)cnc1C#N |
| InChI | InChI=1S/C21H23N7O3/c1-13-12-31-5-4-28(13)20(29)11-25-16-6-15(8-23-17(16)7-22)18-9-26-19(10-24-18)27-21(30)14-2-3-14/h6,8-10,13-14,25H,2-5,11-12H2,1H3,(H,26,27,30) |
| InChIKey | OFSAJHQVIKCNBS-UHFFFAOYSA-N |
| XLogP | 1.42 |
| TPSA | 133.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 421.46 |
| LogP ≤ 5 | 1.42 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121271891 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.